Stock CYTO ALTAMIRA THERAPEUTICS
Add to a list
To use this feature you must be a member
Log inSign up

MarketScreener Editorial Features Altamira Therapeutics Nasdaq

Equities

CYTO

BMG0360L2099

Market Closed - Nasdaq
Other stock markets
 04:30:01 2024-05-14 pm EDT 		5-day change 1st Jan Change
1.44 USD 0.00% Intraday chart for Altamira Therapeutics -8.86% -58.62%
May. 01 Altamira Therapeutics Ltd. Announces Filing of Provisional Patent Application for OligoPhore Nanoparticles with siRNA Targeting p65 Protein in Treatment of Cancer and Inflammation CI
Apr. 24 Altamira Therapeutics Ltd. Announces Publication of Positive Results from Bentrio Trial in Seasonal Allergic Rhinitis in Top Peer Reviewed Journal CI

MarketScreener Editorial Features

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CYTO Stock
  4. CYTO Stock
  5. News Altamira Therapeutics
  6. MarketScreener Editorial Features
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW